Developing new treatments for emerging infectious diseases in infectious and noninfectious diseases has attracted a particular attention. The emergence of viral diseases is expected to accelerate; these data indicate the need for a proactive approach to develop widely active family specific and cross family therapies for future disease outbreaks. Viral disease such as pneumonia, severe acute respiratory syndrome type 2, HIV infection, and Hepatitis-C virus can cause directly and indirectly cardiovascular disease (CVD). Emphasis should be placed not only on the development of broad-spectrum molecules and antibodies but also on host factor therapy, including the reutilization of previously approved or developing drugs. Another new class of therapeutics with great antiviral therapeutic potential is molecular communication networks using deep learning autoencoder (DL-AEs). The use of DL-AEs for diagnosis and prognosis prediction of infectious and noninfectious diseases has attracted a particular attention. MCN is map to molecular signaling and communication that are found inside and outside the human body where the goal is to develop a new black box mechanism that can serve the future robust healthcare industry (HCI). MCN has the ability to characterize the signaling process between cells and infectious disease locations at various levels of the human body called point-to-point MCN through DL-AE and provide targeted drug delivery (TDD) environment. Through MCN, and DL-AE healthcare provider can remotely measure biological signals and control certain processes in the required organism for the maintenance of the patient's health state. We use biomicrodevices to promote the real-time monitoring of human health and storage of the gathered data in the cloud. In this paper, we use the DL-based AE approach to design and implement a new drug source and target for the MCN under white Gaussian noise. Simulation results show that transceiver executions for a given medium model that reduces the bit error rate which can be learned. Then, next development of molecular diagnosis such as heart sounds is classified. Furthermore, biohealth interface for the inside and outside human body mechanism is presented, comparative perspective with up-to-date current situation about MCN.
Deep learning (DL) is a branch of machine learning and artificial intelligence that has been applied to many areas in different domains such as health care and drug design. Cancer prognosis estimates the ultimate fate of a cancer subject and provides survival estimation of the subjects. An accurate and timely diagnostic and prognostic decision will greatly benefit cancer subjects. DL has emerged as a technology of choice due to the availability of high computational resources. The main components in a standard computer-aided design (CAD) system are preprocessing, feature recognition, extraction and selection, categorization, and performance assessment. Reduction of costs associated with sequencing systems offers a myriad of opportunities for building precise models for cancer diagnosis and prognosis prediction. In this survey, we provided a summary of current works where DL has helped to determine the best models for the cancer diagnosis and prognosis prediction tasks. DL is a generic model requiring minimal data manipulations and achieves better results while working with enormous volumes of data. Aims are to scrutinize the influence of DL systems using histopathology images, present a summary of state-of-the-art DL methods, and give directions to future researchers to refine the existing methods.
The range of effectiveness of the novel corona virus, known as COVID-19, has been continuously spread worldwide with the severity of associated disease and effective variation in the rate of contact. This paper investigates the COVID-19 virus dynamics among the human population with the prediction of the size of epidemic and spreading time. Corona virus disease was first diagnosed on January 30, 2020 in India. From January 30, 2020 to April 21, 2020, the number of patients was continuously increased. In this scientific work, our main objective is to estimate the effectiveness of various preventive tools adopted for COVID-19. The COVID-19 dynamics is formulated in which the parameters of interactions between people, contact tracing, and average latent time are included. Experimental data are collected from April 15, 2020 to April 21, 2020 in India to investigate this virus dynamics. The Genocchi collocation technique is applied to investigate the proposed fractional mathematical model numerically via Caputo-Fabrizio fractional derivative. The effect of presence of various COVID parameters e.g. quarantine time is also presented in the work. The accuracy and efficiency of the outputs of the present work are demonstrated through the pictorial presentation by comparing it to known statistical data. The real data for COVID-19 in India is compared with the numerical results obtained from the concerned COVID-19 model. From our results, to control the expansion of this virus, various prevention measures must be adapted such as self-quarantine, social distancing, and lockdown procedures.